KNSA

Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares (KNSA)

About Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares (KNSA)

Kiniksa Pharmaceuticals International Plc is a commercial-stage biopharmaceutical company. It engages in discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical need. The company was founded on April 9, 2024 and is headquartered in London, United Kingdom.

Details

Daily high

$78.73

Daily low

$75.90

Price at open

$77.12

52 Week High

$82.94

52 Week Low

$35.20

Market cap

6.0B

Dividend yield

Volume

482,846

Avg. volume

540,287

P/E ratio

78.54

Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares News